- cross-posted to:
- [email protected]
- cross-posted to:
- [email protected]
FDA approves gene-editing treatment for sickle cell disease::The CRISPR-based treatment edits DNA in adult stem cells without crossing bioethical boundaries
You must log in or register to comment.